Possible significance of the pharmacological differentiation of beta-blockers for therapy of hypertension

British Journal of Clinical Pharmacology
F H Leenen

Abstract

1 Cardioselective and non-selective beta-blockers affect to a different degree several aspects of the circulatory homeostasis. The evidence available in this regard has been evaluated and the possible clinical importance of these differences has been discussed. 2 Venous return in partly regulated by beta-receptors (possibly of the beta 2 type) in the venous resistance vessels. Differences in blockade of venous return by the two classes of beta-blockers may, therefore, influence the degree of increase in left ventricular size, left ventricular end diastolic BPs and stroke volume during beta-blockade. 3 At the first part of the dose-reponse curve, non-selective beta-blockers seem to block more effectively renin release than cardioselective beta-blockers. 4 The direction and the extent to which beta-blockers 'directly' affect total peripheral resistance (TPR), is determined by the resultant of the degree of decrease in TPR by blockade of renin release and the extent of the increase in TPR by blockade of the beta 2-receptors in the arteriolar wall. 5 The clinical relevance of these differences could be that--especially in the low doses range--non-selective beta-blockers may be more 'safe' in patients with compromised cardiac functi...Continue Reading

References

Sep 1, 1976·Clinical Pharmacology and Therapeutics·M GuazziF Magrini
Feb 1, 1978·British Heart Journal·P B DecalmerG M Sterling
Jan 1, 1978·Annual Review of Physiology·I A ReidW F Ganong
Dec 1, 1978·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·F H LeenenG G Geyskes
Jul 8, 1976·The New England Journal of Medicine·J W HollifieldD G Shand
Sep 30, 1976·European Journal of Clinical Pharmacology·J F De PlaenT Reybrouck
Jul 1, 1977·The American Journal of Cardiology·A Zweifler, M D Esler
Dec 2, 1976·The New England Journal of Medicine·H GavrasH R Brunner
Jan 1, 1975·Clinical and Experimental Pharmacology & Physiology·J F GreenR Zelis
Mar 1, 1975·Clinical and Experimental Pharmacology & Physiology·J F Green
Jul 11, 1975·Clinical Pharmacology and Therapeutics·F H LeenenR H McDonald
May 1, 1974·Clinical Pharmacology and Therapeutics·M D Esler
Apr 1, 1966·The American Journal of Cardiology·W S HarrisA M Weissler

Citations

Jan 1, 1992·European Journal of Clinical Pharmacology·S H ThomasS E Smith
Jul 1, 1984·The Annals of Otology, Rhinology, and Laryngology·L W PrattJ F Tryzelaar
May 21, 2009·Journal of Cardiovascular Pharmacology·George Bakris

Related Concepts

Adrenergic beta-Antagonists
Capillary Resistance
Cardiac Output
Hypertensive Disease
Preprorenin

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.